(Reuters) – Drugmaker SIGA Technologies said on Tuesday it has received orders worth about $28 million for its oral antiviral drug Tpoxx, as monkeypox cases spread globally.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)
(Reuters) – Drugmaker SIGA Technologies said on Tuesday it has received orders worth about $28 million for its oral antiviral drug Tpoxx, as monkeypox cases spread globally.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)
